Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05539118
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-09-14
First Post:
2022-08-17
Brief Title:
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Melanoma |
Keywords:
| Name | View |
|---|---|
| Melanoma unresectable Interferon-alfa1b Toripalimab Anlotinib | View |